Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's the extraordinary vision I was referring to.. now put it to good use on the upside!
Yes.. but not too difficult to predict a reversal from an over hyped 600% rise in a overbought ticker. Lets see this extraordinary vision on the height and timing of the next uptrend that will inevitably take place. If that happens I'll be the first to send congratulations!
This ticker will test the fine line between patience and whatever(you name it). All you can do is have confidence in what you own and hold with the thoughts of all in or go home!
Looks like the laundry may be done for today!
It's a little premature to stick a fork in this ticker and say it's done. The stock is resilient. It has gone thru ten years of no revenue. A PPS high and low. Very poor management. Toxic finance deals. A name change. Two reverse splits. Total operational shut down. Consultants that bled the company out of cash. Two yrs of total silence all in a very competitive cure cancer bio world. Most would have thrown the towel in by now. Yet, the company has managed to stay SEC current and is just one deal or partnership or revenue source away going forward and that news will blow the top off this ticker.
I doubt very seriously that it will happen today but that is as far as I'm willing to venture a stock price in the future!
Zip Code changer although no one specified what zip code your moving to!
The 8K on 3/6 announced another 250,000 loan (debenture) from Sabby. When going over the details I was wondering why such a near term mature date of July. Seems strange!
NSPX did all that was required that is be current with reporting. The run to .037 was nothing of their doing it was all speculation from traders. Now everyone is blaming NSPX for not reporting news which they obviously don't have. When the fun is over everyone heads to the exits in mass pointing fingers at everyone but themselves.
Trade the dbl bottom at .0015 .. safe entry. Go for it!
Perfect price action to get the short time "day tripper" out of the way and let smart money buy and fortify their accounts for what lies ahead. Take another look at what you own and try to justify this PPS.
Now you got it..this is and always has been an issue of what is NSPX going to do do with all the DD IP Patents etc. that are supposed to be the value of this company. Until the company parlays all of it for real value (cash) everything is just an exercise in mental guess work! The only thing that is real is the PPS at the present moment. With studying the fundamentals of this ticker it's easy to form an opinion that the stock is going to go up.. it's much harder to nail WHEN this will happen.
Yea right! Keep believing your plan. The truth is that there is probably no deal or merger or buyout to report at the present time and the stock price reflects that. The anticipation drove the price up to recent levels now reality is setting in. It may drift back to the lows who knows. You should not buy this stock on the action of a 30 min candle chart. Forget the current price and buy with a target sell well above current action. Hold with patience until your targets are hit..if they don't get hit your plan did not materialize. that's the nature of stock investing!
This is what patience looks like. Either you believe in what you own or not! My last fill was 2/12 at .004 and will sell 1/2 at first target and the rest at second. May take a while but believe it will get there!
Yea! Lots of great insight to tell that stocks are going down in a down correction from recent highs. Sock trading 101
YEA.. probably lots of buds are not buds any more.
I want to own NSPX but am wanting a lower price for my buy order. Have read all the DD and this is a sure winner. Can't you tell buy my last 17 posts! It's only a matter of time!
Know what you own and who was behind the drugs in the NSPX pipeline. The drugs were not developed in some basement lab by some random dude when the surf was not up or mad scientist. Real drugs with real possibility developed by known experts.
Lewis and Clark Pharmaceuticals, Inc. (L&C Pharma) is an early stage drug development company focusing on adenosine receptor-based therapies for a wide range of inflammatory, autoimmune, and other underserved chronic diseases. L&C Pharma was founded in 2011 by Robert Thompson, Ph.D., an acknowledged world leader in adenosine chemistry.
You are right on! Don't listen to me think for yourself! I base my optimism that this is going boom is on a simple theory. No one individual or group owns NSPX. Sabby has been keeping this ticker alive! Sabby as of last filing owed 40% of OS. It is possible that when the AS gets maxed out Sabby will again own 40% of AS. 60,000,000 shares. (150,000,000 x 40%). I don't believe Sabby will be satisfied with a .01 stock or a .10 stock but a price for some serious cash for their effort of keeping this ticker alive. So some time in the future, no one knows when or if, an event will take place or an situation will develop that escalates the stock price. For the privilege of being able to be a part of this escalation, if it happens and it may not, I am willing to put some expendable cash on the line. I may be wrong and my loss will only effect my account. It is important that every one forms their own plan and theory and invest accordingly.
I agree.. i don't believe anyone who states shares owned, profits made, entry prices, sell prices, and all the rests of the boasts and garbage that is stated. I only know and believe or care about the details profits or loses of one account mine. I don't care if others make a fortune of loose a fortune or if this is a $10.00 stock or a POS. I only listen to one person.. me.
Yea.. mm took out some sell stops below .01 eat them up like PAC MAN! Dlb OO's are not the end of world been there before.. those who bought subs and sold 03's did well. Some good vacation money if you could actually get out of the house! Any scent of news and this does a repeat!
No real damage here..low volume no news slide that has keep buyers from taking over the trade..holding the 50 DMA, moving to oversold and consolidating @.01.. momentum currently bearish but that can turn quickly as we saw the move from.005 to .037! Being in is better than being out.. it's a strange time anything can happen. crystal balls can get cloudy when the world's gone crazy!
Sounds like you have a trading plan that works for you! I'm happy for you Good luck!
Clarify .. 99% of the ones that LOOSE money do that because they don't adhere to tried and true investing and/or trading tactics that have been proven over time and one of the biggest culprits for losses is believing that others are smarter than yourself and you should listen to their BS.
Maybe some buyers will come this afternoon at these levels thinking that just maybe something might develop over the weekend. Could end green.
correct.. they have a knack of being on the wrong side of the move. I learned the hard way years ago in the commodity markets that your first plan with patience is usually your best plan!
Just rinsing out sell stops below .01 for some weekend beer money!
Also, not buying any more. I followed this ticker a long time and waited and loaded up in the subs. I heed the modern day philosopher Alfred E. Neuman.. "What Me Worry?"
The company care for shareholders is about equal to the care penny stock flippers have for the company.
Your question of why nspx has not been more attractive to big pharma is a valid one and really at the root of the low PPS over time. I still believe that the cause of this is that there is too much work to do and money to be expended before NSPX has a commercial drug. NSPX flagship drug Mipsagargins' development has been stymied by a lack of supply chain for the active ingredient thagsagargin. The next step for this drug is a PH III trial. Why would any company invest large sums of money in a drug only to have it sit on the self until/or when the supply chain improves while there are other valid companies with drug platforms that are much farther along with larger drug pipelines that can be bringing in revenue sooner? Big pharma is big business and business does not like dead money. Although I've been a critic of Chris Lowe he is savvy and saw the writing on the wall and shut down all unnecessary expenditures. Since Feb 2018 NSPX has only spent money on SEC compliance and costs associated with that compliance. Sabby has kept the company alive for what reason? Nspx has no debt other than Sabby and some left over payables. As long as sabby keeps the funding coming NSPX is going to continue on until something major comes out concerning their drug platforms. This can happen anytime or longer! Stay tuned. To some the share price on the 30 min chart is everything but the PPS really doesn't matter much because your gamble is the PPS sometime in the future.
Both AS increase and R/S require majority shareholder approval and there is no indication that those are even in the works. Total speculation and scare tactics on your part. The last two R/S were approved months before they actually went into effect. Remember there are some that actually read the filings and understand the true facts of this ticker!
If you are persistent you could try these 4.
Colin Hislop.. he presently works at Eiger BioPharmaceuticals
Michael Cain.. he works at Level 4 services
Chris Lowe ex ceo he works at FLG Partners
Conor Flannery.. He works a Jll Property managers
Don't expect to much many have tried and came up empty. If you do happen to get thru make sure that any questions you ask can not be construed as them giving out any inside information.
Good Luck
Long money is smart money.. don't second guess yourself.. there is too much in the ticker to ignore the upside. Look hard at all the DD and facts and you'll make a smart decision where else on the OTC would you want to park your money for low risk and possible very high reward.
The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease.. Article in FASEB journal relating to the effect of adenosine on hypertension.
Studies around the world are trying to find why the association of hypertension induced heart and lung disease has enhanced COVID-19 deaths. A report released on April 8 stated that as many as 72% of the deaths in patients over 65 also suffered from hypertension.
No real technical damage..drifting toward oversold and holding above 50 DMA nothing to get nervous about! A break below .01 may wash it out but it also could rally into the weekend. Don't get antsy about news probably won't happen soon so deal with it!
Everyone got excited about NSPX having drugs similar to remdasivir's adenosine and rightly so.. the connection may still prove itself out. However when nothing immediate came out and the reality that this may take a while the interest faded. Most have very short leashes on these type stocks. NSPX needs to prove itself and so far with it's silence has proven nothing other than it has a bunch of IP and patents that only optimistic investors (like myself) think are valuable. The company in general is only worth .0125 per outstanding share as it trades this morning. That's all.
Unfortunately that is all we have so that is reality. The misconception that most have is that this is an actual pharmaceutical company and that it is structured as such. It is NOT! That ended in 2018 when Chris Lowe shut the operational functions of the company down for lack of funds. Since then and I believe it will continue as a entity that relies on others to carry on investigative work and/or research on its IP and Patents and at the same time it pursues agreements to license, partner or sell those IP and patents outright or the entire company. As this structure it does not need an office or lab or employees or any of the envisioned attributes that most think would be incorporated in an actual pharma co. It has morphed into a broker co not dissimilar to your neighborhood realtor.
In order to answer the phone they first need a company phone to answer. If they did have a company phone and did answer the phone what would you expect them to tell you that is legal under the Sarbans-Oxley insider trading information act. They are current with all sec filings and I think that is all we should expect.
The certificates of incorporation authorized 30,000,000 of "BLANK CHECK" shares of preferred stock. In january 19 the board (which Chris Lowe was a member) used this authorization to issue 5000 shares of Series D Preferred stock. The transaction is noted on pg 33 of the 10_Q for period ending 3/31/19 Under ReSale of Unregistered Securities. These Preferred stock went to Flannery so he had majority of votes to rubber stamp Chris Lowe's R/S. This all happened in jan 19 so the notice that the sharehold vote was not required for the R/s since flannery had voted for it. Chris Lowe was not good for NSPX all he did was line FLG and his pockets.
Chris Lowe needed somebody with majority voting power to get anything he came up with thru.. obviously he didn't want the common stockholders voting on a R?S. He and Flannery had previous business dealings. A sweet deal for Flannery for $ 5000 he got option of 1,000,000 shares of common at .005 which mean he paid nothing for the preferred stock. Whether he is actually behind the wheel of NSPX is a question..who knows?